Pharmacokinetics, metabolism and biliary and urinary excretion of oral ramipril in man. 1995

M Verho, and C Luck, and W J Stelter, and B Rangoonwala, and N Bender
Hoechst AG, Frankfurt am Main, Germany.

In order to evaluate the pharmacokinetics and excretion of ramipril in man, 8 cholecystectomy patients aged between 53 and 68 years received 5 mg ramipril orally as a single dose. All patients had a T-drain inserted to permit bile collection; all gave their informed consent to participate in the trial. Serum samples were collected half-hourly until 2 hours, then hourly until 6 hours, then at 8, 10, 24 and 25 hours after intake. Urine was collected in 2-hour fractions until 8 hours, followed by a 4- and a 12-hour fraction. Bile was collected hourly until 6 hours, followed by a 6- and a 12-hour collecting fraction. Concentrations of ramipril and ramiprilat in serum, and determinations in urine and bile of ramipril, ramiprilat, ramipril glucuronide, ramiprilat glucuronide, diketopiperazine and diketopiperazine acid were made; total amounts excreted were calculated. Peak concentrations of ramiprilat in plasma (8.7 +/- 1.6 ng/ml) were reached after about 8 hours. AUC0-8 and AUC0-24-values were 36.5 and 111.9 ng.h/ml, respectively. Ramiprilat Cmax-concentrations were about 300-fold higher in bile than in plasma, the corresponding difference for ramipril between bile and plasma was about 4-fold. The main fractions excreted in the urine were diketopiperazine acid and ramiprilat amounting to 13.2 +/- 5.6 and 4.4 +/- 2.4%, respectively, of the dose administered. Only a very small fraction of the dose was excreted with urine as unchanged ramipril, on average 0.9 +/- 1.0%. The main fractions excreted in the bile were diketopiperazine acid, ramiprilat glucuronide and diketopiperazine, 9.0 +/- 5.3, 3.4 +/- 4.2 and 2.0 +/- 1.2% in 24 hours, respectively, of the dose administered. Only a negligible fraction of the dose (average 0.1 +/- 0.1%) was excreted with bile as unchanged ramipril. In conclusion, there is strong evidence that circulating ramipril and ramiprilat are eliminated by both the liver and the kidneys. For the patients studied it can be estimated from late collection periods that some 2/3 of circulating ramipril and ramiprilat are eliminated by the kidneys and 1/3 eliminated by the liver.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002763 Cholecystectomy Surgical removal of the GALLBLADDER. Cholecystectomies
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

M Verho, and C Luck, and W J Stelter, and B Rangoonwala, and N Bender
September 1983, Chemical & pharmaceutical bulletin,
M Verho, and C Luck, and W J Stelter, and B Rangoonwala, and N Bender
January 1983, European journal of clinical pharmacology,
M Verho, and C Luck, and W J Stelter, and B Rangoonwala, and N Bender
January 1988, European journal of clinical pharmacology,
M Verho, and C Luck, and W J Stelter, and B Rangoonwala, and N Bender
November 1991, European journal of anaesthesiology,
M Verho, and C Luck, and W J Stelter, and B Rangoonwala, and N Bender
May 1988, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
M Verho, and C Luck, and W J Stelter, and B Rangoonwala, and N Bender
February 1986, Pharmaceutisch weekblad. Scientific edition,
M Verho, and C Luck, and W J Stelter, and B Rangoonwala, and N Bender
November 1983, Bulletin de la Societe de pathologie exotique et de ses filiales,
M Verho, and C Luck, and W J Stelter, and B Rangoonwala, and N Bender
February 1972, Endocrinology,
M Verho, and C Luck, and W J Stelter, and B Rangoonwala, and N Bender
February 1980, Journal of steroid biochemistry,
M Verho, and C Luck, and W J Stelter, and B Rangoonwala, and N Bender
April 1989, American journal of veterinary research,
Copied contents to your clipboard!